These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 7579736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens.
    Baleriola C, Johal H, Robertson P, Jacka B, Whybin R, Taylor P, Rawlinson WD.
    Cell Tissue Bank; 2012 Jun; 13(2):251-8. PubMed ID: 21476143
    [Abstract] [Full Text] [Related]

  • 5. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
    Dangel V, Bäder U, Enders G.
    J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI, Lyamuya EF, Mbena EC, Magessa PM, Sufi J, Marwa GJ, Mwasulama OJ, Mbwana J.
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H, Japanese Red Cross NAT Screening Research Group.
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
    Candotti D, Mundy C, Kadewele G, Nkhoma W, Bates I, Allain JP.
    J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
    [Abstract] [Full Text] [Related]

  • 19. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E, Ouedraogo T, Ganamé J, Fickenscher H, Kynast-Wolf G, Becher H, Kouyaté B, Kräusslich HG, Sangaré L, Tebit DM.
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [Abstract] [Full Text] [Related]

  • 20. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
    Aswad S, Khan NS, Comanor L, Chinchilla C, Corado L, Mone T, Mendez R, Mendez R.
    J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.